Developer docs
API playgroundTry for free, no card

Search company profiles

MediSapiens

Full company profile

uuid000gfet

Namestring
MediSapiens
Websiteurl
medisapiens.com
Company typeenum
Private
Founded yearint
2009
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHelsinki, Finland
HQ citystring
Helsinki
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
biopharmaceutical research software, surgical decision support, medical AI integration, robotic-assisted surgery AI, healthcare imaging analytics
Industry3 codes
1Surgical Robotics & Computer-Assisted Surgery Platforms
CodeHLAHADAFPrimaryYes
2SaMD – Imaging & Signal Analysis (AI/ML)
CodeHLACANAGPrimaryNo
3Healthcare & Assistive Robotics
CodeHDAAAIACPrimaryNo
NAICS code2 codes
  • Software Publishers513210
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
Product category
Healthcare AI Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1AI Technology Licensing/Integration
TypeLicensing Royalties
Description

Revenue generated through partnerships with major medical device companies like Boston Scientific, integrating AI decision support capabilities into surgical systems

wiseguyreports.com
Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

MediSapiens is a software company developing online applications for biopharmaceutical researchers, with a focus on AI-driven decision support technology for surgical workflows. Its technology is designed to be integrated into robotic-assisted surgical care pathways, enabling AI-enabled imaging capabilities and intelligent data analysis to support healthcare professionals during procedures, with revenue generated through licensing and integration partnerships with major medical device manufacturers such as Boston Scientific.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1AI-driven Surgical Decision Support
CategorySurgical Decision Support Software
Description

Artificial intelligence technology designed to be integrated into surgical workflows, providing decision support capabilities for healthcare professionals during robotic-assisted procedures. Targeted at medical device manufacturers seeking to embed AI capabilities into their surgical platforms.

2AI-enabled Imaging Integration
CategorySurgical Imaging AI
Description

AI-enabled imaging capability that enhances decision-making during procedures by embedding intelligent image analysis into robotic-assisted surgical care pathways. Sold as part of the AI integration offering to partner surgical systems.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-20
Description

Boston Scientific has partnered with MediSapiens to integrate AI-driven decision support into surgical workflows. This partnership positions MediSapiens' AI technology for deployment within Boston Scientific's robotic-assisted surgical care pathways. The collaboration enables AI-enabled imaging capabilities to be embedded into surgical systems, enhancing decision-making during procedures.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Intuitive Surgical (da Vinci) is the dominant incumbent in robotic-assisted surgery and increasingly bundles its own AI-driven decision support, analytics, and imaging. Comparable as a broad incumbent shaping the category where MediSapiens' AI decision support is being integrated.

TypeDirect peer
Description

Brainlab provides AI-driven surgical planning, imaging, and intra-operative decision support software that is integrated into OEM surgical platforms. Highly comparable to MediSapiens' AI decision-support approach for surgical workflows and its OEM-licensing business model.

TypeBroad incumbent
Description

Medtronic competes via the Hugo robotic-assisted surgery platform and Digital Surgery (Touch Surgery) AI assets. Comparable as an incumbent OEM that could either partner with or compete against MediSapiens' AI decision support offering.

TypeDirect peer
Description

Caresyntax sells AI-powered surgical analytics and decision-support tooling to hospitals and medical device manufacturers. Directly comparable as a B2B AI surgical data platform targeting the same enterprise buyer (device OEMs and providers) that MediSapiens serves.

TypeBroad incumbent
Description

Stryker's Mako robotic surgery platform and its broader digital ecosystem (including OrthoSensor/AI planning) represents a large incumbent in AI-enabled robotic surgery. Comparable because it is a potential second OEM customer for MediSapiens-style decision support.

TypeDirect peer
Description

Gauss Surgical builds AI-enabled decision-support tools used in surgical settings (e.g., blood loss estimation). Comparable to MediSapiens as a focused AI surgical software vendor licensing into hospital/surgical workflows.

TypeEmerging player
Description

Arterys provides AI-powered medical imaging analytics (cardiac, lung, oncology) integrated into clinical workflows. Comparable as an AI/ML healthcare software vendor with a similar technology profile (clinical AI for decision support) and enterprise SaaS/licensing model.

TypeDirect peer
Description

Activ Surgical develops AI-driven intra-operative decision support and visualization for minimally invasive and robotic surgery. Directly comparable in technology category (real-time AI surgical guidance) and in OEM commercialization strategy.

TypeEmerging player
Description

Proprio uses AI and light-field imaging to provide real-time surgical guidance and visualization. Comparable as an emerging AI-surgical-imaging/guidance player aiming to integrate with robotic-assisted surgery platforms, similar to MediSapiens' Boston Scientific use case.

TypeEmerging player
Description

Surgical Safety Technologies sells AI-based intra-operative safety and decision-support analytics used in OR settings. Comparable as an emerging player in AI-driven intra-operative decision support targeting similar surgical workflows.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MediSapiens

Healthcare AI Softwaremedisapiens.com

MediSapiens firmographics

Firmographics
Name
MediSapiens
Website
https://medisapiens.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

MediSapiens industry classification

Industry
Product category
Healthcare AI Software
NAICS
Software Publishers (513210), Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
akta.pro primary industry
Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
akta.pro secondary industries
SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Healthcare & Assistive Robotics (HDAAAIAC)

Keywords

  • Biopharmaceutical research software
  • Surgical decision support
  • Medical AI integration
  • Robotic-assisted surgery AI
  • Healthcare imaging analytics

Where MediSapiens is headquartered

Location

Headquarters

HQ city
Helsinki
HQ country
Finland
HQ region
Europe

Markets served

MediSapiens business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. AI Technology Licensing/Integration: Revenue generated through partnerships with major medical device companies like Boston Scientific, integrating AI decision support capabilities into surgical systems

Go-to-market motion1 record

MediSapiens product offering

Product offering

Core offering

MediSapiens is a software company developing online applications for biopharmaceutical researchers, with a focus on AI-driven decision support technology for surgical workflows. Its technology is designed to be integrated into robotic-assisted surgical care pathways, enabling AI-enabled imaging capabilities and intelligent data analysis to support healthcare professionals during procedures, with revenue generated through licensing and integration partnerships with major medical device manufacturers such as Boston Scientific.

Differentiator

Problem solved

Functional benefit

Products and services

  • AI-driven Surgical Decision Support Artificial intelligence technology designed to be integrated into surgical workflows, providing decision support capabilities for healthcare professionals during robotic-assisted procedures. Targeted at medical device manufacturers seeking to embed AI capabilities into their surgical platforms.
  • AI-enabled Imaging Integration AI-enabled imaging capability that enhances decision-making during procedures by embedding intelligent image analysis into robotic-assisted surgical care pathways. Sold as part of the AI integration offering to partner surgical systems.

Companies that use MediSapiens

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

MediSapiens technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

MediSapiens partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Boston ScientificcoreStrategic or Co-development Partner · 20 April 2026Boston Scientific has partnered with MediSapiens to integrate AI-driven decision support into surgical workflows. This partnership positions MediSapiens' AI technology for deployment within Boston Scientific's robotic-assisted surgical care pathways. The collaboration enables AI-enabled imaging capabilities to be embedded into surgical systems, enhancing decision-making during procedures.

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

MediSapiens competitors and assessment

Company assessment

Broad incumbents

  • Intuitive Surgical: Intuitive Surgical (da Vinci) is the dominant incumbent in robotic-assisted surgery and increasingly bundles its own AI-driven decision support, analytics, and imaging. Comparable as a broad incumbent shaping the category where MediSapiens' AI decision support is being integrated.
  • Medtronic (Hugo / Digital Surgery): Medtronic competes via the Hugo robotic-assisted surgery platform and Digital Surgery (Touch Surgery) AI assets. Comparable as an incumbent OEM that could either partner with or compete against MediSapiens' AI decision support offering.
  • Stryker (Mako): Stryker's Mako robotic surgery platform and its broader digital ecosystem (including OrthoSensor/AI planning) represents a large incumbent in AI-enabled robotic surgery. Comparable because it is a potential second OEM customer for MediSapiens-style decision support.

Direct peers

  • Brainlab: Brainlab provides AI-driven surgical planning, imaging, and intra-operative decision support software that is integrated into OEM surgical platforms. Highly comparable to MediSapiens' AI decision-support approach for surgical workflows and its OEM-licensing business model.
  • Caresyntax: Caresyntax sells AI-powered surgical analytics and decision-support tooling to hospitals and medical device manufacturers. Directly comparable as a B2B AI surgical data platform targeting the same enterprise buyer (device OEMs and providers) that MediSapiens serves.
  • Gauss Surgical: Gauss Surgical builds AI-enabled decision-support tools used in surgical settings (e.g., blood loss estimation). Comparable to MediSapiens as a focused AI surgical software vendor licensing into hospital/surgical workflows.
  • Activ Surgical: Activ Surgical develops AI-driven intra-operative decision support and visualization for minimally invasive and robotic surgery. Directly comparable in technology category (real-time AI surgical guidance) and in OEM commercialization strategy.

Emerging players

  • Arterys: Arterys provides AI-powered medical imaging analytics (cardiac, lung, oncology) integrated into clinical workflows. Comparable as an AI/ML healthcare software vendor with a similar technology profile (clinical AI for decision support) and enterprise SaaS/licensing model.
  • Proprio Vision: Proprio uses AI and light-field imaging to provide real-time surgical guidance and visualization. Comparable as an emerging AI-surgical-imaging/guidance player aiming to integrate with robotic-assisted surgery platforms, similar to MediSapiens' Boston Scientific use case.
  • Surgical Safety Technologies (OR Black Box): Surgical Safety Technologies sells AI-based intra-operative safety and decision-support analytics used in OR settings. Comparable as an emerging player in AI-driven intra-operative decision support targeting similar surgical workflows.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

MediSapiens social profiles

Digital presence

MediSapiens financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MediSapiens leadership team

Management profile

Number of profiles

Profiles5 records

MediSapiens funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MediSapiens M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MediSapiens

What does MediSapiens do?

MediSapiens is a software company developing online applications for biopharmaceutical researchers, with a focus on AI-driven decision support technology for surgical workflows. Its technology is designed to be integrated into robotic-assisted surgical care pathways, enabling AI-enabled imaging capabilities and intelligent data analysis to support healthcare professionals during procedures, with revenue generated through licensing and integration partnerships with major medical device manufacturers such as Boston Scientific.

When was MediSapiens founded?

MediSapiens was founded in 2009. It employs 11 to 50 people.

Where is MediSapiens based?

MediSapiens is headquartered in Helsinki, Finland, in the Europe region.

How does MediSapiens make money?

One revenue line is on record: AI Technology Licensing/Integration.

Who are MediSapiens's main competitors?

Broad incumbents on record are Intuitive Surgical, Medtronic (Hugo / Digital Surgery) and Stryker (Mako). Direct peers are Brainlab, Caresyntax, Gauss Surgical and Activ Surgical. Emerging players are Arterys, Proprio Vision and Surgical Safety Technologies (OR Black Box).

Does MediSapiens have an API?

No public API is recorded for MediSapiens.

What industry is MediSapiens in?

MediSapiens's product category is Healthcare AI Software. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireMediSapiens Partners With Modul-Bio to Provide an All-Round Biobanking CapabilityMediSapiens, a Helsinki and Cambridge-based developer of genomic and biomedical data solutions, has partnered with Modul-Bio, a Marseille-based provider of biological sample management and biobank information management systems. The partnership aims to offer biobanks an integrated end-to-end solution combining sample management and data management capabilities, enabling clients to manage, share, and commercialize their biological samples and data. Both companies bring complementary expertise to support the biobanking field with the goal of making new research insights more accessible.PR NewswireMediSapiens Partners With Mars Petcare to Foster New Developments in Precision HealthcareMars Petcare has partnered with MediSapiens to advance precision healthcare for companion animals, building on MediSapiens' existing work developing genetic testing systems for MyDogDNA. The partnership follows Mars Petcare's acquisition of Genoscoper Laboratories, a long-time partner of MediSapiens. The collaboration aims to accelerate discovery of genetic health markers and promote better health for companion animals using precision healthcare technologies.PR NewswireMediSapiens Joins the FinnGen Project and Brings Solutions to Curation, Management and Visualization of Genetic and Clinical Data of 500.000 FinnsMediSapiens has joined the FinnGen project, which aims to improve human health by genetically profiling 500,000 Finns and combining this data with clinical information. The project has a total funding of 59 million euros, with MediSapiens providing software solutions for data curation and management, enabling the identification of new therapeutic targets and disease markers. The initiative is expected to enhance healthcare systems and patient outcomes through innovative research and personalized treatments.